FINERENONE | FINERENONE | ATC C03DA05
CARDIOVASCULAR NON STEROIDAL MINERALOCORTICOID RECEPTOR ANTAGONIST (MRA) TREATMENT OF PATIENTS WITH CHRONIC KIDNEY DISEASE ASSOCIATED WITH TYPE 2 DIABETES | ORAL | Cmax 422.8 NANOMOLAR Tmax 0.8 HOUR F 44 PERCENT VD 52.6 LITER PPB 92 PERCENT Cl 25 LITER / HOUR HT 2.5 HOUR SOLUBILITY PRACTICALLY INSOLUBLE IN WATER | MINERALOCORTICOID RECEPTOR | Mineralocorticoid receptor UNIPROT P08235 more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |